Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
1999-02-04^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2001-01-15^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20010005998-A |
titleOfInvention |
Yeast Strains with Interrupted ATF2 Gene and Uses |
abstract |
The present invention relates to a modified yeast strain in which 3β-hydroxysteroid is stabilized by removing the APAT activity by altering a gene encoding acetyl-CoA pregnenolone acetyltransferase (APAT) activity. |
priorityDate |
1998-02-05^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |